A method for simultaneous analysis of miRNA and protein at single-cell level using flow cytometry

Flow cytometry is a powerful technique that enables rapid analysis of millions of individual cells while detecting multiple proteins simultaneously. A significant limitation has been the unavailability of antibodies against non-protein targets, such as microRNA (miRNA), long non-coding RNA (lncRNA), and mRNA. However, the introduction of the PrimeFlow RNA Assay (Thermo Fisher Scientific) addresses this challenge by enabling combined analysis of RNA molecules with protein abundance via flow cytometry. miRNAs represent a distinct class of epigenetic regulators that modulate gene expression at the post-transcriptional level. Different miRNAs are known to regulate normal immune functions and inflammation; the strong and consistent changes seen in miRNA expression in asthma highlights their potential as biomarkers of disease, as well as attractive therapeutic targets for pathway-specific immune modulation. In this study, we utilized the established relationship of miR-150-5p regulation of B cell development to provide a detailed protocol that enables simultaneous assessment of specific miRNAs across distinct cellular subtypes/differentiation stages. Our results confirm dynamic miR-150-5p expression during B cell development in the bone marrow of mice, including a striking abundance of miR-150-5p in mature B cells over immature B cell populations. To our knowledge, this is the first study to describe the expression of miR-150-5p across distinct developmental stages of B cells. The PrimeFlow RNA Assay represents a sensitive and specific approach for analysis of protein expression and miRNA regulation of cellular processes at a single-cell level. The optimized step-by-step protocol presented here is easily adapted for studies of other immune cells and noncoding RNAs in ex vivo and in vitro settings. Detailed understanding of regulatory pathways could provide novel insight into the mechanisms underlying allergy and asthma, as well as other inflammatory conditions.

Authors

Institutions

Publication Details

Journal
Frontiers in Allergy
Published
2026-11-16
DOI
https://doi.org/10.3389/falgy.2026.1982877
Primary Topic
MicroRNA in disease regulation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A method for simultaneous analysis of miRNA and protein at single-cell level using flow cytometry

Jenny Calvén, Sophia‐Louise Noble, Hannes Ingelhag, Hiba Sayedali et al.
Frontiers in Allergy
MicroRNA in disease regulation
article

A method for simultaneous analysis of miRNA and protein at single-cell level using flow cytometry

Jenny Calvén, Sophia‐Louise Noble, Hannes Ingelhag, Hiba Sayedali, Kristina Johansson, Madeleine Rådinger, Carina Malmhäll
article en

Abstract

Flow cytometry is a powerful technique that enables rapid analysis of millions of individual cells while detecting multiple proteins simultaneously. A significant limitation has been the unavailability of antibodies against non-protein targets, such as microRNA (miRNA), long non-coding RNA (lncRNA), and mRNA. However, the introduction of the PrimeFlow RNA Assay (Thermo Fisher Scientific) addresses this challenge by enabling combined analysis of RNA molecules with protein abundance via flow cytometry. miRNAs represent a distinct class of epigenetic regulators that modulate gene expression at the post-transcriptional level. Different miRNAs are known to regulate normal immune functions and inflammation; the strong and consistent changes seen in miRNA expression in asthma highlights their potential as biomarkers of disease, as well as attractive therapeutic targets for pathway-specific immune modulation. In this study, we utilized the established relationship of miR-150-5p regulation of B cell development to provide a detailed protocol that enables simultaneous assessment of specific miRNAs across distinct cellular subtypes/differentiation stages. Our results confirm dynamic miR-150-5p expression during B cell development in the bone marrow of mice, including a striking abundance of miR-150-5p in mature B cells over immature B cell populations. To our knowledge, this is the first study to describe the expression of miR-150-5p across distinct developmental stages of B cells. The PrimeFlow RNA Assay represents a sensitive and specific approach for analysis of protein expression and miRNA regulation of cellular processes at a single-cell level. The optimized step-by-step protocol presented here is easily adapted for studies of other immune cells and noncoding RNAs in ex vivo and in vitro settings. Detailed understanding of regulatory pathways could provide novel insight into the mechanisms underlying allergy and asthma, as well as other inflammatory conditions.

Frontiers in AllergyVol. 7
University of Gothenburg (SE)
Göteborgs Universitet
Good health and well-being
MicroRNA in disease regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon